Dashboard · Pharmaceuticals stocks · SUNPHARMA
84
JayScore

Sun Pharmaceutical Industries Limited

SUNPHARMA Pharmaceuticals
High Conviction Grade A+ 72% confidence
Score computed at ₹1,880.00 · 16 Nov 2026
Research signals 0 positive · 8 cautionary of 8
NSE
JayScore
84
vs
Sector signal
6
84
Sun Pharmaceutical Industries Limited SUNPHARMA High Conviction
Get notified when this stock's JayScore changes
Free account — score alerts, daily research picks, morning plan and portfolio tracker.
Sign Up Free Sign In
About Sun Pharmaceutical Industries Limited

Sun Pharmaceutical Industries Limited is a Pharmaceuticals company listed on the National Stock Exchange (NSE) with a market capitalisation of ₹4.51 lakh crore. The company reports ROE of 13.1%, a net profit margin of 17.8%. Revenue grew +11.9% year-over-year. Promoter holding stands at 55.6%, with FII participation at 29.5%.

Pharmaceuticals sector signal: 6/100 — below-average — fewer than 40% of sector peers are trading above their EMA 20.
JayScore 84/100 indicates a strong research signal — multiple technical and fundamental factors are aligned positively. JayScore is a quantitative index — not investment advice. Learn how it's calculated →
JaySense Research View · quantitative signals only · not investment advice
High Conviction

Price is rising consistently (EMA alignment — short and medium-term averages both pointing up). Buying pressure is building (RSI/MACD momentum confirmed). A trend-following indicator is on the bullish side (SuperTrend signal: buy). The uptrend is visible even on the weekly chart (longer-term trend confirmed). Above-average delivery percentage suggests real buying, not just speculation (delivery 63%). Both short and medium-term trend lines are pointing upward — the trend has momentum (rising EMA20 + EMA50). Foreign institutions have been net buyers for 3 consecutive days — sustained institutional demand (✅ FII buying streak).

Positive Signals
Price is trending above key moving averages
5 of 9 research signals are converging positively
Watch Points
Fundamental score is weak relative to benchmark
Valuation appears stretched on current metrics
Growth momentum has slowed materially
Institutional activity is low or declining
Research Score Insight

Sun Pharmaceutical Industries Limited scores 84/100 (High Conviction Research Signal). The strongest signals are Trend (17/100) and Momentum (13/100). The weakest dimension is Valuation (0/100), which warrants monitoring. This reflects JaySense quantitative research scoring only — not investment advice. Consult a SEBI Registered Investment Adviser before making any investment decision.

Trend 17 Momentum 13 Volume 6 Fundamental 3 Valuation 0 Growth 2 Institutional 1 Sector 6 Risk 6
Research Intelligence Free Account Required
0 positive · 9 risk signals identified 5 / 9 signals converging
Downtrend active — price has broken below key moving averages
Institutional indicators suggest active accumulation in this price zone
Volatility ratio and momentum signal caution at current levels
Institutional indicators suggest active accumulation in this price zone
Volatility ratio and momentum signal caution at current levels

8 more research signals — available free with a JaySense account

Get Free Access Sign in
Sector & Institutional Activity Free Account Required
Sector Health
6.4000/100
Sector Rank
#3 of 12
FII Activity
Net Buying
FII net buyers ₹840 Cr over last 10 sessions — institutional accumulation in progress
DII activity supportive — domestic funds adding to position

Sector peer rank, FII/DII trend & institutional activity — free with a JaySense account

Get Free Access Sign in
Score Analysis
Trend
17
Weak
Price vs moving averages · trend structure
Momentum
13
Weak
MACD · RSI · rate-of-change
Volume
6
Weak
Volume strength · accumulation vs distribution
Fundamental
3
Weak
Margins · returns · debt ratios
Valuation
0
Weak
PE · PB · multiples vs sector
Growth
2
Weak
Revenue & profit growth YoY
Sector
6
Weak
Sector relative strength vs market
Risk
6
Weak
Volatility · beta · drawdown risk
Institutional
1
Weak
FII / DII participation & block deals
Signal convergence: 5 / 9 dimensions aligned · Moderate convergence
Score Trend (Last 30 Scores)
Fundamentals
Market Cap
₹4.51 L Cr
P/E Ratio
41.14
P/B Ratio
5.05
EPS (TTM)
45.7
ROE
13.1%
ROCE
—
Net Profit Margin
17.8%
Debt / Equity
3.62
Revenue Growth YoY
11.9%
Profit Growth YoY
-36.2%
Promoter Holding
55.6%
FII Holding
29.5%
Dividend Yield
0.9%
Company Profile
Sun Pharmaceutical Industries Limited is a Pharmaceuticals company listed on the National Stock Exchange (NSE) with a market capitalisation of ₹4.51 lakh crore. The company reports ROE of 13.1%, a net profit margin of 17.8%. Revenue grew +11.9% year-over-year. Promoter holding stands at 55.6%, with FII participation at 29.5%.
Corporate Actions
Corporate Actions Source: NSE
Recent History
₹5.00 / share
07 Jul 2026
Dividend
Related Research — Same Sector
Stock Score Signal
AUROPHARMA
Aurobindo Pharma Limited
75 High Conviction
APOLLOHOSP
Apollo Hospitals Enterprise Limited
73 High Conviction
DIVISLAB
Divi's Laboratories Limited
72 High Conviction
CIPLA
Cipla Limited
69 Positive Setup
GLENMARK
Glenmark Pharmaceuticals Limited
60 Positive Setup
How JaySense scores stocks Full stock screener
Disclaimer: JaySense scores are research outputs based on technical and fundamental signals. They are not buy/sell recommendations and do not constitute investment advice. Past score performance does not guarantee future returns. Please do your own research or consult a SEBI-registered investment advisor before making any investment decision. JaySense is not SEBI-registered. Use this platform for educational and research purposes only.